Company intelligence / Profile preview

BioAssays

Ownership: Private
Development stage: Commercial

Overview

BioAssay Systems (USA) develops and manufactures assay kits. Bioassay GmbH (Germany) provides validated bioanalytical assays and potency testing services under GMP/GLP conditions. Neither company develops therapeutics themselves, thus they do not have clinical results or a drug pipeline.

Therapeutic areas: Other
Modalities: ProteinsMonoclonal antibodyVaccineGene therapySmall molecule
Industry: Contract Research Organization

Partnerships

Not specifically disclosed. Both serve major pharma/biotech clients globally.

Beyond the preview

Go deeper on BioAssays.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioAssays.

Explore the full profile